Literature DB >> 24434363

Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.

Adi Hersalis Eldar1, Joab Chapman2.   

Abstract

Immune mediated neuropathies are uncommon but important to diagnose because they are potentially treatable. This chapter summarizes the clinical approach to diagnosis of Guillain Barré syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and related neuropathies which are thought to be caused by direct autoimmune attack on peripheral nerves.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic inflammatory demyelinating polyradiculoneuropathy; Guillain Barré syndrome; Multifocal motor neuropathy; POEMS

Mesh:

Substances:

Year:  2014        PMID: 24434363     DOI: 10.1016/j.autrev.2014.01.033

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  13 in total

1.  Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients.

Authors:  Mohan S Maddur; Magalie Rabin; Pushpa Hegde; Francis Bolgert; Moneger Guy; Jean-Michel Vallat; Laurent Magy; Jagadeesh Bayry; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

3.  Role of environmental factors in autoimmunity: pearls from the 10th international Congress on autoimmunity, Leipzig, Germany 2016.

Authors:  Carlo Perricone; Guido Valesini
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

4.  Biopsy Characteristics, Subtypes, and Prognostic Features in 107 Cases of Feline Presumed Immune-Mediated Polyneuropathy.

Authors:  Ninja Kolb; Kaspar Matiasek; Jana van Renen; Andrea Fischer; Yury Zablotski; Franziska Wieländer; Jasmin Nessler; Andrea Tipold; Rodolfo Cappello; Thomas Flegel; Shenja Loderstedt; Josephine Dietzel; Kirsten Gnirs; Kai Rentmeister; Stephan Rupp; Thilo von Klopmann; Frank Steffen; Konrad Jurina; Omar V Del Vecchio; Martin Deutschland; Florian König; Gualtiero Gandini; Tom Harcourt-Brown; Marion Kornberg; Ezio Bianchi; Teresa Gagliardo; Marika Menchetti; Henning Schenk; Joana Tabanez; Marco Rosati
Journal:  Front Vet Sci       Date:  2022-06-24

5.  [Segmental testicular infarction. Unusual complication of intravenous immunoglobulin therapy for multifocal motor neuropathy].

Authors:  J Rüb; R Rehmann; N von Landenberg; F Roghmann; P Stude; M Tegenthoff; J Noldus; J Pastor
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

Review 6.  Guillain-Barré syndrome in Colombia: where do we stand now?

Authors:  María P Mahecha; Ernesto Ojeda; Daniel A Vega; Juan C Sarmiento-Monroy; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  Value of nerve biopsy in patients with latent malignant hemopathy and peripheral neuropathy: a case series.

Authors:  Mathilde Duchesne; Stéphane Mathis; Philippe Corcia; Laurence Richard; Karima Ghorab; Arnaud Jaccard; Laurent Magy; Jean-Michel Vallat
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

8.  Depression with Chronic Inflammatory Demyelinating Polyneuropathy.

Authors:  Arun Marwale; Manaswi Gautam; Gaurav Murambikar; Manik Bhise; Anand Soni
Journal:  Indian J Psychol Med       Date:  2018 Nov-Dec

9.  Guillain-Barre Syndrome After Robotically Assisted Laparoscopic Prostatectomy: First Case Report.

Authors:  Jaschar Shakuri-Rad; Patrick W Gavin; Shawn P Todd; Tony T Tran; Cody R Christensen; Kenneth F Shockley; Thomas J Maatman
Journal:  Urol Case Rep       Date:  2015-02-10

10.  Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: A case report.

Authors:  Jong Youb Lim; Young-Ho Lim; Eun-Hi Choi
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.